Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival.

Winkelmann, Michael; Rejeski, Kai; Blumenberg, Viktoria; Bücklein, Veit L; Ruzicka, Michael; Unterrainer, Marcus; Schmidt, Christian; Dekorsy, Franziska J; Bartenstein, Peter; Ricke, Jens; von Bergwelt-Baildon, Michael; Subklewe, Marion; Kunz, Wolfgang G.

Afiliação

Winkelmann M; Department of Radiology, University Hospital, LMU Munich, Germany.
Rejeski K; Department of Medicine III, University Hospital, LMU Munich, Germany.
Blumenberg V; Department of Medicine III, University Hospital, LMU Munich, Germany.
Bücklein VL; Department of Medicine III, University Hospital, LMU Munich, Germany.
Ruzicka M; Department of Medicine III, University Hospital, LMU Munich, Germany.
Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Germany.
Schmidt C; Department of Medicine III, University Hospital, LMU Munich, Germany.
Dekorsy FJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Germany.
Ricke J; Comprehensive Cancer Center München-LMU (CCCM), LMU Munich, Germany.
von Bergwelt-Baildon M; Department of Radiology, University Hospital, LMU Munich, Germany.
Subklewe M; Comprehensive Cancer Center München-LMU (CCCM), LMU Munich, Germany.
Kunz WG; Department of Medicine III, University Hospital, LMU Munich, Germany.

Hemasphere ; 6(10): e781, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36187874

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article